SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis

Slingshot homolog-1 (SSH1) plays an important role in pathological processes, including in the occurrence and development of tumours. The purpose of this study was to determine whether SSH1 is a key biomarker with prognostic value for survival in patients with gastric cancer. We performed immunohist...

Full description

Saved in:
Bibliographic Details
Published in:BMC gastroenterology 2018-01, Vol.18 (1), p.12-12, Article 12
Main Authors: Maimaiti, Yusufu, Maimaitiming, Maimaitiaili, Li, Yiliang, Aibibula, Saifuding, Ainiwaer, Azatijiang, Aili, Aikebaier, Sun, Zhenzhu, Abudureyimu, Kelimu
Format: Article
Language:English
Subjects:
Cancer cells
Development and progression
Gastric cancer
Gene expression
Genetic aspects
Prognosis
Progression
SSH1
Stomach cancer
Survival analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Slingshot homolog-1 (SSH1) plays an important role in pathological processes, including in the occurrence and development of tumours. The purpose of this study was to determine whether SSH1 is a key biomarker with prognostic value for survival in patients with gastric cancer. We performed immunohistochemistry (IHC) on tissue microarrays containing 100 gastric cancer specimens to evaluate SSH1 protein expression. The association of pathological characteristics with cumulative survival was determined by Kaplan-Meier analysis. A Cox proportional hazards model was generated in the multi-factorial survival analysis to identify univariate prognostic factors of GC. SSH1 expression level in gastric cancer tissues was significantly associated with lymph node metastasis (P = 0.032). Additionally, multivariate regression analysis clearly indicated that SSH1 expression was significantly correlated with poor clinical outcomes of patients with gastric cancer (P = 0.016). Multivariate analyses showed that SSH1 was the best predictor of poor prognosis in patients with gastric cancer (P = 0.030). SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis. SSH1 may play an important role in the development of gastric cancer, and it is a promising target for prevention and/or treatment of gastric cancer.
ISSN:1471-230X
1471-230X
DOI:10.1186/s12876-018-0739-5